Task: Answer the MCQ question.
Query: Which compound exhibits a -12.276% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) COc1cc(OC)cc(-c2n[nH]c(=S)n2-c2cc(OC)ccc2OC)c1
b.) COc1cc(/C=C/C(=O)O)cc(S(=O)(=O)NCCCO)c1OC
c.) Cc1cc(C)nc(NC(=O)CSc2nnnn2-c2ccccc2)n1
d.) O=C(Nc1nccs1)c1cccc(S(=O)(=O)N2CCCCC2)c1
Answer: c. Cc1cc(C)nc(NC(=O)CSc2nnnn2-c2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(NC(=O)CSc2nnnn2-c2ccccc2)n1
Cc1cc(C)nc(NC(=O)CSc2nnnn2-c2ccccc2)n1
N-(4,6-dimethylpyrimidin-2-yl)-2-(1-phenyltetrazol-5-yl)sulfanylacetamide